<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Scorpion toxins have been central to the investigation and understanding of the physiological role of <z:chebi fb="120" ids="26216">potassium</z:chebi> (K⁺) channels and their expansive function in membrane biophysics </plain></SENT>
<SENT sid="1" pm="."><plain>As highly specific probes, toxins have revealed a great deal about channel structure and the correlation between mutations, altered regulation and a number of human pathologies </plain></SENT>
<SENT sid="2" pm="."><plain>Radio- and fluorescently-labeled toxin isoforms have contributed to localization studies of channel subtypes in expressing cells, and have been further used in competitive displacement assays for the identification of additional novel ligands for use in research and medicine </plain></SENT>
<SENT sid="3" pm="."><plain>Chimeric toxins have been designed from multiple <z:chebi fb="7" ids="16670">peptide</z:chebi> scaffolds to probe channel isoform specificity, while advanced <z:chebi fb="0" ids="53000">epitope</z:chebi> chimerization has aided in the development of novel molecular therapeutics </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="7" ids="16670">Peptide</z:chebi> backbone cyclization has been utilized to enhance therapeutic efficiency by augmenting serum stability and toxin half-life in vivo as a number of K⁺-channel isoforms have been identified with essential roles in <z:mp ids='MP_0002054'>disease states</z:mp> ranging from HIV, T-cell mediated <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> to various <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> and <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">Malaria</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Bioengineered scorpion toxins have been monumental to the evolution of channel science, and are now serving as templates for the development of invaluable experimental molecular therapeutics </plain></SENT>
</text></document>